In-Office Whitening System for Tooth Discoloration
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new in-office teeth whitening system called NextGen to evaluate its effectiveness compared to other popular options like Opalescence and Zoom. The study aims to determine which system whitens teeth more effectively. Participants will receive treatments directly on their teeth and compare results. Suitable candidates have natural front teeth, good oral health, and have not used professional whitening products in the past year. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to the approval of a potentially effective new whitening system.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on dental health and whitening products, so it's best to ask the study team for guidance.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the NextGen In-office Whitening System is generally safe. Studies have found that tooth sensitivity is the most common side effect, causing temporary tingling or discomfort in some users. This is common with many teeth whitening products.
The NextGen system is currently in a late-stage trial, indicating some evidence of safety from earlier tests. However, individual experiences may vary. Prospective participants should discuss any concerns with the trial team.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the NextGen In-Office Whitening System because it combines traditional whitening gel with an innovative LED tray, potentially enhancing the whitening effect in less time. Unlike typical in-office whitening treatments like Opalescence or Zoom, which involve longer or similar application times, NextGen reduces each session to just 15 minutes. This shorter treatment time, coupled with the LED technology, could mean quicker results for patients seeking brighter smiles.
What evidence suggests that this trial's whitening systems could be effective for tooth discoloration?
Research shows that in-office teeth whitening systems, such as the NextGen In-office Whitening System, can effectively whiten teeth. Studies have found that systems using hydrogen peroxide, like NextGen, noticeably lighten teeth quickly. Early results suggest that NextGen's use of an LED tray enhances its whitening power. This trial will compare the NextGen system to other systems, such as Opalescence and Zoom, tested in separate treatment arms. In-office treatments can deliver visible results in just a few sessions. Overall, these treatments are designed to safely provide a brighter smile.12678
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 18-70 with natural front teeth (teeth #6 through #11) and a certain level of tooth darkness. They must be in good general and oral health, not pregnant or lactating, without allergies to whitening products, and have no recent dental cleanings or whitening treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive in-office whitening treatment using different systems, including Opalescence, NextGen, and Zoom, with sessions involving application of whitening gel and use of LED or lamp devices.
Follow-up
Participants are monitored for tooth shade whitening improvements immediately after treatment and 1 week later.
What Are the Treatments Tested in This Trial?
Interventions
- NextGen In-office Whitening System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Colgate Palmolive
Lead Sponsor
Noel Wallace
Colgate Palmolive
Chief Executive Officer since 2019
MBA from Harvard Business School
Diana Haussling
Colgate Palmolive
Chief Marketing Officer since 2022
Bachelor's degree in Marketing